|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 9/10/12 Hi Tech Pharmacal Co Inc 10-Q 7/31/12 64:3.3M Donnelley … Solutions/FA |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 319K
2: EX-31.1 Certification -- §302 - SOA'02 HTML 24K
3: EX-31.2 Certification -- §302 - SOA'02 HTML 24K
4: EX-32 Certification -- §906 - SOA'02 HTML 18K
41: R1 Document and Entity Information HTML 38K
31: R2 Condensed Consolidated Balance Sheets HTML 120K
39: R3 Condensed Consolidated Balance Sheets HTML 39K
(Parenthetical)
43: R4 Condensed Consolidated Statements of Operations HTML 94K
(Unaudited)
58: R5 Consolidated Statements of Comprehensive Income HTML 34K
(Unaudited)
33: R6 Condensed Consolidated Statements of Cash Flows HTML 80K
38: R7 Basis of Presentation HTML 29K
28: R8 Business HTML 22K
20: R9 Revenue Recognition HTML 21K
59: R10 Net Income Per Share HTML 23K
45: R11 Accounts Receivable HTML 55K
44: R12 Inventory HTML 28K
49: R13 Property and Equipment HTML 33K
50: R14 Intangible Assets HTML 52K
48: R15 Long-Term Debt HTML 25K
51: R16 Freight Expense HTML 20K
40: R17 Stock-Based Compensation HTML 35K
42: R18 Product Divestitures HTML 22K
47: R19 Income Taxes HTML 26K
63: R20 Contingencies and Other Matters HTML 47K
54: R21 Recent Accounting Pronouncements HTML 28K
35: R22 Significant Customers and Concentration of Credit HTML 25K
Risk
46: R23 Fair Value Measurements HTML 37K
37: R24 Segment Information HTML 53K
15: R25 Accounts Receivable (Tables) HTML 51K
55: R26 Inventory (Tables) HTML 26K
60: R27 Property and Equipment (Tables) HTML 31K
24: R28 Intangible Assets (Tables) HTML 42K
23: R29 Stock-Based Compensation (Tables) HTML 29K
26: R30 Fair Value Measurements (Tables) HTML 27K
27: R31 Segment Information (Tables) HTML 44K
29: R32 Net Income Per Share (Details) HTML 19K
14: R33 Accounts Receivable (Details) HTML 28K
52: R34 Accounts Receivable (Details 1) HTML 32K
34: R35 Accounts Receivable (Details Textual) HTML 21K
36: R36 Inventory (Details) HTML 29K
18: R37 Property and Equipment (Details) HTML 34K
62: R38 Property and Equipment (Details Textual) HTML 29K
11: R39 Intangible Assets (Details) HTML 47K
30: R40 Intangible Assets (Details Textual) HTML 97K
57: R41 Long-Term Debt (Details) HTML 45K
17: R42 Freight Expense (Details) HTML 19K
22: R43 Stock-Based Compensation (Details) HTML 26K
25: R44 Stock-Based Compensation (Details Textual) HTML 42K
32: R45 Product Divestitures (Details) HTML 34K
13: R46 Income Taxes (Details) HTML 25K
19: R47 Contingencies and Other Matters (Details) HTML 65K
12: R48 Significant Customers and Concentration of Credit HTML 25K
Risk (Details)
56: R49 Fair Value Measurements (Details) HTML 23K
16: R50 Fair Value Measurements (Details Textual) HTML 20K
53: R51 Segment Information (Details) HTML 35K
61: XML IDEA XML File -- Filing Summary XML 91K
21: EXCEL IDEA Workbook of Financial Reports (.xls) XLS 456K
5: EX-101.INS XBRL Instance -- hitk-20120731 XML 686K
7: EX-101.CAL XBRL Calculations -- hitk-20120731_cal XML 118K
8: EX-101.DEF XBRL Definitions -- hitk-20120731_def XML 233K
9: EX-101.LAB XBRL Labels -- hitk-20120731_lab XML 722K
10: EX-101.PRE XBRL Presentations -- hitk-20120731_pre XML 484K
6: EX-101.SCH XBRL Schema -- hitk-20120731 XSD 141K
64: ZIP XBRL Zipped Folder -- 0001193125-12-386176-xbrl Zip 82K
| EX-32 |
Exhibit 32
HI-TECH PHARMACAL CO., INC.
CERTIFICATION PURSUANT TO 18 U. S. C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF
THE SARBANES-OXLEY ACT OF 2002
Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officers of Hi-Tech Pharmacal Co., Inc. (the “Company”), hereby certify to such officers’ knowledge, that the Company’s Quarterly Report on Form 10-Q for the period ended July 31, 2012 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934 and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: September 7, 2012
| /s/ David S. Seltzer |
| Chief Executive Officer |
| /s/ William Peters |
| Chief Financial Officer |
This certification is being furnished solely pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 9/10/12 | None on these Dates | ||
| 9/7/12 | ||||
| For Period end: | 7/31/12 | |||
| List all Filings | ||||